PetDx

Pet Dx

Biotechnology, San Diego Us, San Diego, California, United States, 51-200 Employees

petdx.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 80********

Who is PETDX

PetDx The Liquid Biopsy Company for PetsTM is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The companys flagship pr...

Read More

map
  • San Diego Us, San Diego, California, United States Headquarters: San Diego Us, San Diego, California, United States
  • 2019 Date Founded: 2019
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from PETDX

PetDx Org Chart and Mapping

Employees

John Donovin

Business Development Manager

Justin French

Marketing Lead Manager

Dana Tsui

Chief Scientific Officer

Daniel Grosu

Founder & Chairman of the Board

Victoria Burke

Associate Director of Sales Enablement and Inbound Team Manager

Julie Jordan

Senior Sales and Commercial Development Manager

Katarina Pantic

Clinical Laboratory Technician II

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding PetDx

Answer: PetDx's headquarters are located at San Diego Us, San Diego, California, United States

Answer: PetDx's phone number is 80********

Answer: PetDx's official website is https://petdx.com

Answer: PetDx's revenue is $25 Million to $50 Million

Answer: PetDx's SIC: 8731

Answer: PetDx has 51-200 employees

Answer: PetDx is in Biotechnology

Answer: PetDx contact info: Phone number: 80******** Website: https://petdx.com

Answer: PetDx The Liquid Biopsy Company for PetsTM is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The companys flagship product, OncoK9, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatic algorithms empowering veterinarians to provide superior care to canine patients.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access